Media

Bioscience industry a bright spot among the technology sector
The 2014 BIO International Convention, where the global biotech community meets, connecting the people, companies and innovations that help to fulfill the...

Press Releases

Dec 22 2000
WASHINGTON, D.C. (December 22, 2000) - The Biotechnology Industry Organization (BIO) will host the third annual CEO & Investor Conference, "Investing...
Dec 18 2000
Lee Rawls, Chief of Staff to US Senator Bill Frist, Named BIO's new Vice President for Government Relations WASHINGTON, D.C. (December 18, 2000) – “I am...
Dec 7 2000
New HealthFest 2001 Event and “Partnering for Life” ThemeExpected to Attract 12,000 WASHINGTON, D.C. (December 7, 2000) – San Diego will host the Biotechnology...
Nov 21 2000
WASHINGTON, D.C. (November 21, 2000) -- The Biotechnology Industry Organization (BIO) achieved significant legislative objectives during the 106th Congress...
Nov 17 2000
WASHINGTON (November 17, 2000)-The Biotechnology Industry Organization (BIO) today named Matthew D. Lyons director of government relations for food and...
Oct 19 2000
WASHINGTON (October 19, 2000)-The Environmental Protection Agency (EPA) reaffirmed Thursday that a review of all available scientific information indicates...
Oct 19 2000
At the strong urging of the Environmental Protection Agency, Aventis is announcing today that they are canceling the registration of StarLink corn. This means...
Oct 18 2000
WASHINGTON, D.C. (October 18, 2000) - Biotechnology Industry Organization (BIO) President, Carl B. Feldbaum, today issued the following statement on the drug...
Oct 16 2000
WASHINGTON, D.C. (October 16, 2000) -- The Biotechnology Industry Organization (BIO) has asked the U.S. Court of Appeals for the Federal Circuit for a...


Biotechnology News

July 21, 2014

SAN DIEGO--(BUSINESS WIRE)--Assay Depot Inc., the pharmaceutical industry’s leading marketplace for scientific services, today announced a partnership to build an academic...

July 21, 2014

BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology, Inc. (Nasdaq: CLVS) will announce its second quarter 2014 financial results on Thursday, August 7, 2014, after the close...

July 21, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Announces Advancement of Ganetespib into Phase 3 Extension of AML LI-1 Study for Patients with AML and High-Risk MDS

July 21, 2014

DUBLIN & LEXINGTON, Mass.--(BUSINESS WIRE)--Jazz Pharmaceuticals and Concert Pharmaceuticals initiated a first-in-human Phase 1 study with JZP-386.

July 21, 2014

ST. PAUL, Minn.--(BUSINESS WIRE)--World leaders and celebrities came to St. Paul, Minn. to support and celebrate the Starkey Hearing Foundation’s 14th annual So the World...